{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:13:32Z","timestamp":1793747612451,"version":"4.6.1"},"reference-count":163,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIH\/NEI","award":["EY-12963"],"award-info":[{"award-number":["EY-12963"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surveyophthalmol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.survophthal.2016.12.010","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T17:45:56Z","timestamp":1482428756000},"page":"816-827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":154,"title":["Management of high-risk corneal transplantation"],"prefix":"10.1016","volume":"62","author":[{"given":"Antonio","family":"Di Zazzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Kheirkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tulio B.","family":"Abud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2439-4780","authenticated-orcid":false,"given":"Sunali","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00007890-199908150-00011","article-title":"Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group","volume":"68","year":"1999","journal-title":"Transplantation"},{"issue":"2 Suppl","key":"10.1016\/j.survophthal.2016.12.010_bib2","first-page":"1","article-title":"The Australian Corneal Graft Registry. 1990 to 1992 report","volume":"21","year":"1993","journal-title":"Aust N Z J Ophthalmol"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib3","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1001\/archopht.1992.01080220054021","article-title":"The collaborative corneal transplantation studies (CCTS). Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group","volume":"110","year":"1992","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2016.12.010_bib4","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1097\/ICO.0000000000000942","article-title":"Outcomes of penetrating keratoplasty with imported corneas compared with local corneas","volume":"35","author":"Ababneh","year":"2016","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib5","first-page":"CD007603","article-title":"Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty","author":"Abudou","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib6","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/ICO.0000000000000198","article-title":"Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization","volume":"33","author":"Agarwal","year":"2014","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib7","first-page":"CD009561","article-title":"Artificial corneas versus donor corneas for repeat corneal transplants","author":"Akpek","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2\u20133","key":"10.1016\/j.survophthal.2016.12.010_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib9","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.4049\/jimmunol.1600251","article-title":"Alloimmunity and tolerance in corneal transplantation","volume":"196","author":"Amouzegar","year":"2016","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bjophthalmol-2015-306837","article-title":"Descemet membrane endothelial keratoplasty","volume":"100","author":"Ang","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib11","first-page":"75","article-title":"[Intracorneal depot\u00a0steroids for the treatment of corneal rejection after\u00a0keratoplasty]","volume":"79","author":"Arenas","year":"2004","journal-title":"Arch Soc Esp Oftalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib12","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2567.2007.02581.x","article-title":"Blockade of the 4-1BB\u00a0(CD137)\/4-1BBL and\/or CD28\/CD80\/CD86 costimulatory\u00a0pathways promotes corneal allograft\u00a0survival in mice","volume":"121","author":"Asai","year":"2007","journal-title":"Immunology"},{"issue":"9","key":"10.1016\/j.survophthal.2016.12.010_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0167-5699(93)90243-E","article-title":"Safety and efficacy of therapeutic monoclonal antibodies in clinical therapy","volume":"14","author":"Bach","year":"1993","journal-title":"Immunol Today"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00347-014-3053-9","article-title":"[Pediatric corneal surgery and corneal transplantation]","volume":"112","author":"Bachmann","year":"2015","journal-title":"Ophthalmologe"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib15","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0161-6420(92)31996-7","article-title":"Corneal laser photocoagulation for treatment of neovascularization","volume":"99","author":"Baer","year":"1992","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2165\/00063030-199912050-00005","article-title":"Mycophenolate mofetil: a review of its use in the management of solid organ transplantation","volume":"12","author":"Bardsley-Elliot","year":"1999","journal-title":"BioDrugs"},{"issue":"6","key":"10.1016\/j.survophthal.2016.12.010_bib17","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jfo.2016.01.009","article-title":"[Management of corneal neovascularization prior to corneal transplantation: Report of 112 cases]","volume":"39","author":"Belghmaidi","year":"2016","journal-title":"J\u00a0Fr Ophtalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib18","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0161-6420(89)32756-4","article-title":"Topical cyclosporine in high-risk corneal transplants","volume":"96","author":"Belin","year":"1989","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00003226-199007000-00002","article-title":"Update on topical cyclosporin A. Background, immunology, and pharmacology","volume":"9","author":"Belin","year":"1990","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jop.1996.12.425","article-title":"FK-506 delays corneal graft rejection in a model of corneal xenotransplantation","volume":"12","author":"Benelli","year":"1996","journal-title":"J\u00a0Ocul Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib21","first-page":"1256","article-title":"Efficacy of sub-conjunctival and topical bevacizumab in high-risk corneal transplant survival","volume":"63","author":"Bhatti","year":"2013","journal-title":"J\u00a0Pak Med Assoc"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib22","first-page":"519","article-title":"Efficacy of topical bevacizumab in high-risk corneal transplant survival","volume":"29","author":"Bhatti","year":"2013","journal-title":"Pakistan J Med Sci"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib23","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/01.TP.0000158022.62059.F2","article-title":"Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study","volume":"79","author":"Birnbaum","year":"2005","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib24","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1038\/eye.2008.402","article-title":"Mycophenolate mofetil (MMF) following penetrating high-risk keratoplasty: long-term results of a prospective, randomised, multicentre study","volume":"23","author":"Birnbaum","year":"2009","journal-title":"Eye (Lond)"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib25","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.tp.0000191291.71003.1b","article-title":"An open prospective pilot study on the use of rapamycin after penetrating high-risk keratoplasty","volume":"81","author":"Birnbaum","year":"2006","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1034\/j.1399-0039.2002.590507.x","article-title":"Predicting time on the waiting list for HLA matched corneal grafts","volume":"59","author":"B\u00f6hringer","year":"2002","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib27","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0161-6420(93)31409-0","article-title":"Risk factors of corneal graft failure","volume":"100","author":"Boisjoly","year":"1993","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ophtha.2011.07.057","article-title":"Long-term results of deep anterior lamellar versus penetrating keratoplasty","volume":"119","author":"Borderie","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.survophthal.2016.12.010_bib29","first-page":"1017","article-title":"Effects of the new anti-lymphocytic peptide cyclosporin A in animals","volume":"32","author":"Borel","year":"1977","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003226-199401000-00001","article-title":"The high-risk keratoplasty patient\u2013quo vadis?","volume":"13","author":"Bouchard","year":"1994","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib31","first-page":"503","article-title":"Effect of cyclosporin A on the T-effector and T-suppressor cell response in contact sensitivity","volume":"59","author":"Braida","year":"1986","journal-title":"Immunology"},{"issue":"8557","key":"10.1016\/j.survophthal.2016.12.010_bib32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0140-6736(87)91809-5","article-title":"Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial","volume":"2","author":"Calne","year":"1987","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.survophthal.2016.12.010_bib33","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"CATT Research Group","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajo.2010.03.010","article-title":"Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk","volume":"150","author":"Chatel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.12.010_bib35","first-page":"1","article-title":"Corneal lymphatics: Role in ocular inflammation as inducer and responder of adaptive immunity","volume":"5","author":"Chauhan","year":"2014","journal-title":"J\u00a0Clin Cell Immunol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib36","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1167\/iovs.08-1997","article-title":"Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis","volume":"50","author":"Chen","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"13","key":"10.1016\/j.survophthal.2016.12.010_bib37","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.1167\/iovs.12-10408","article-title":"Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model","volume":"53","author":"Cho","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib38","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1034\/j.1600-6143.2002.20403.x","article-title":"Dendritic cells, tolerance induction and transplant outcome","volume":"2","author":"Coates","year":"2002","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib39","first-page":"1095","article-title":"Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival","volume":"43","author":"Comer","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.survophthal.2016.12.010_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.exer.2015.03.012","article-title":"Corneal angiogenesis modulation by cysteine cathepsins: In\u00a0vitro and in\u00a0vivo studies","volume":"134","author":"Coppini","year":"2015","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/01.ICL.0000062460.03555.32","article-title":"Topical cyclosporine in pediatric keratoplasty","volume":"29","author":"Cosar","year":"2003","journal-title":"Eye Contact Lens"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib42","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.eye.6700634","article-title":"Management of high-risk corneal grafts","volume":"17","author":"Coster","year":"2003","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib43","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","article-title":"Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival","volume":"45","author":"Cursiefen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00003226-200009000-00008","article-title":"Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection","volume":"19","author":"Dana","year":"2000","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib45","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1097\/00007890-199705270-00022","article-title":"Topical interleukin 1 receptor antagonist promotes corneal transplant survival","volume":"63","author":"Dana","year":"1997","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib46","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/ICO.0b013e3181a16472","article-title":"High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen","volume":"28","author":"Dastjerdi","year":"2009","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib47","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.09-3745","article-title":"Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival","volume":"51","author":"Dastjerdi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00417-014-2851-8","article-title":"Three-year corneal graft survival rate in high-risk cases treated with subconjunctival and topical bevacizumab","volume":"253","author":"Dekaris","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/ICO.0b013e3181606086","article-title":"Long-term use of topical tacrolimus (FK506) in high-risk penetrating keratoplasty","volume":"27","author":"Dhaliwal","year":"2008","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/bjo.84.1.107","article-title":"Campath-1H therapy in refractory ocular inflammatory disease","volume":"84","author":"Dick","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib51","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/TP.0000000000000512","article-title":"VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation","volume":"99","author":"Dohlman","year":"2015","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.survophthal.2016.12.010_bib52","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/bjo.83.6.748","article-title":"Amniotic membrane transplantation","volume":"83","author":"Dua","year":"1999","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib53","first-page":"3","article-title":"Corneal allograft rejection: risk factors, diagnosis, prevention, and treatment","volume":"47","author":"Dua","year":"1999","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib54","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bjophthalmol-2012-301828","article-title":"The changing face of corneal graft rejection","volume":"96","author":"Faraj","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib55","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10792-014-9938-4","article-title":"Subconjunctival and\/or intrastromal bevacizumab injections as preconditioning therapy to promote corneal graft survival","volume":"35","author":"Fasciani","year":"2015","journal-title":"Int Ophthalmol"},{"issue":"Suppl 4","key":"10.1016\/j.survophthal.2016.12.010_bib56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2337\/diab.31.4.S11","article-title":"Transplantation without immunosuppression","volume":"31","author":"Faustman","year":"1982","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.survophthal.2016.12.010_bib57","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1073\/pnas.81.12.3864","article-title":"Prevention of rejection of murine islet\u00a0allografts by pretreatment with anti-dendritic cell antibody","volume":"81","author":"Faustman","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","article-title":"Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity","volume":"22","author":"Flechner","year":"2008","journal-title":"Clin Transplant"},{"issue":"6","key":"10.1016\/j.survophthal.2016.12.010_bib59","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archopht.1996.01100130757028","article-title":"Pregnancy and corneal allograft rejection","volume":"114","author":"Fulton","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib60","doi-asserted-by":"crossref","first-page":"863","DOI":"10.4049\/jimmunol.177.2.863","article-title":"Targeted lymphoid homing of dendritic cells is required for prolongation of allograft survival","volume":"177","author":"Garrod","year":"2006","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib61","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/ICU.0b013e3282fb7c33","article-title":"Polypoidal choroidal vasculopathy and treatments","volume":"19","author":"Gomi","year":"2008","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib62","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00007890-199010000-00012","article-title":"Cyclosporine nephrotoxicity in cardiac allograft patients\u2014a seven-year follow-up","volume":"50","author":"Greenberg","year":"1990","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib63","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ajo.2012.09.027","article-title":"Long-term rejection incidence and reversibility after penetrating and lamellar keratoplasty","volume":"155","author":"Guilbert","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib64","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","article-title":"Treatments for corneal neovascularization: a review","volume":"30","author":"Gupta","year":"2011","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1189\/jlb.1011500","article-title":"Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation","volume":"91","author":"Hattori","year":"2012","journal-title":"J\u00a0Leukoc Biol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib66","first-page":"901","article-title":"Use of topical FK506 in a corneal graft rejection model in Lewis rats","volume":"38","author":"Hikita","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib67","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(13)31253-6","article-title":"Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy","volume":"101","author":"Hill","year":"1994","journal-title":"Ophthalmology"},{"issue":"Pt 2","key":"10.1016\/j.survophthal.2016.12.010_bib68","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/eye.1995.48","article-title":"Immunosuppression in corneal transplantation","volume":"9","author":"Hill","year":"1995","journal-title":"Eye (Lond)"},{"issue":"Pt 4","key":"10.1016\/j.survophthal.2016.12.010_bib69","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/eye.1995.99","article-title":"Systemic cyclosporine in high-risk keratoplasty: long-term results","volume":"9","author":"Hill","year":"1995","journal-title":"Eye"},{"issue":"Suppl 10","key":"10.1016\/j.survophthal.2016.12.010_bib70","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/ICO.0000000000000534","article-title":"Management of limbal stem cell deficiency: A historical perspective, past, present, and future","volume":"34","author":"Holland","year":"2015","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib71","first-page":"1990","article-title":"Effect of monoclonal antibody to VLA-4 on corneal allograft survival in mice","volume":"28","author":"Hori","year":"1996","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib72","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/ICO.0b013e31822480f9","article-title":"Anti-VEGF therapy with bevacizumab for anterior segment eye disease","volume":"31","author":"Hosseini","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.survophthal.2016.12.010_bib73","first-page":"4127","article-title":"Dysfunctional regulatory T cells in dry eye disease exacerbate corneal allograft rejection","volume":"53","author":"Hua","year":"2012","journal-title":"ARVO Abstract"},{"issue":"44","key":"10.1016\/j.survophthal.2016.12.010_bib74","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0021-5155(99)00223-3","article-title":"Long-term effects of topical cyclosporine A treatment after penetrating keratoplasty","volume":"3","author":"Inoue","year":"2000","journal-title":"Jpn J Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib75","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0021-5155(01)00339-2","article-title":"Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty","volume":"45","author":"Inoue","year":"2001","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.12.010_bib76","first-page":"381","article-title":"The role of difluprednate ophthalmic emulsion in clinical practice","volume":"3","author":"Jamal","year":"2009","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib77","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjo.2009.172577","article-title":"Efficacy of topical ciclosporin A for treatment and prevention of graft rejection in corneal grafts with previous rejection episodes","volume":"94","author":"Javadi","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib79","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.ico.0000151507.49565.6e","article-title":"Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders","volume":"24","author":"Joseph","year":"2005","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.2006.097428","article-title":"Tacrolimus immunosuppression in high-risk corneal grafts","volume":"91","author":"Joseph","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib81","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/sj.eye.6700565","article-title":"Prospects for gene therapy in corneal disease","volume":"17","author":"Jun","year":"2003","journal-title":"Eye (Lond)"},{"issue":"12","key":"10.1016\/j.survophthal.2016.12.010_bib82","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s00417-003-0759-9","article-title":"HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection","volume":"241","author":"Khaireddin","year":"2003","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.12.010_bib83","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/ICO.0000000000000403","article-title":"Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011)","volume":"34","author":"Kharod-Dholakia","year":"2015","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib84","first-page":"137","article-title":"Studies on the nature of the privilege enjoyed by corneal allografts","volume":"11","author":"Khodadoust","year":"1972","journal-title":"Invest Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2016.12.010_bib85","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1097\/ICO.0b013e31829ebb0d","article-title":"Presurgical corticosteroid treatment improves corneal transplant survival in mice","volume":"32","author":"Kim","year":"2013","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib86","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3341\/kjo.2013.27.4.235","article-title":"The effect of bevacizumab versus ranibizumab in the treatment of corneal neovascularization: a preliminary study","volume":"27","author":"Kim","year":"2013","journal-title":"Korean J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib87","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/01.ico.0000138841.44926.f8","article-title":"Opinions on risk factors and management of corneal graft rejection in the United kingdom","volume":"24","author":"Koay","year":"2005","journal-title":"Cornea"},{"issue":"1 Pt 3","key":"10.1016\/j.survophthal.2016.12.010_bib88","first-page":"3156","article-title":"Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506","volume":"21","author":"Kobayashi","year":"1989","journal-title":"Transplant Proc"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2016.12.010_bib89","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2337\/diab.29.1.S93","article-title":"Effect of culture on islet rejection","volume":"29","author":"Lacy","year":"1980","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/IIO.0b013e3181924e23","article-title":"Corneal graft rejection","volume":"49","author":"Lam","year":"2009","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.survophthal.2016.12.010_bib91","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2147\/OPTH.S35460","article-title":"Suturing techniques and postoperative management in penetrating keratoplasty in the United Kingdom","volume":"6","author":"Lee","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib92","first-page":"2898","article-title":"Angiostatic steroids potentiated by sulfated cyclodextrins inhibit corneal neovascularization","volume":"32","author":"Li","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib93","first-page":"308","article-title":"Clinical and experimental research of corneal lymphangiogenesis after keratoplasty","volume":"222","author":"Ling","year":"2008","journal-title":"Ophthalmol J Int"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib94","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1136\/bjophthalmol-2013-303639","article-title":"Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study","volume":"97","author":"Magalhaes","year":"2013","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2016.12.010_bib95","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0161-6420(94)31138-9","article-title":"Risk factors for corneal graft failure and rejection in the collaborative corneal transplantation studies. Collaborative Corneal Transplantation Studies Research Group","volume":"101","author":"Maguire","year":"1994","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.survophthal.2016.12.010_bib96","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1097\/ICO.0b013e31821e65b3","article-title":"Efficacy of postoperative immunosuppression after keratoplasty in herpetic keratitis","volume":"30","author":"Maier","year":"2011","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib97","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000358167","article-title":"Combined intracorneal and subconjunctival\u00a0bevacizumab injections for recurrent visual loss and intraocular hemorrhage from vascularized fibrous downgrowth","volume":"5","author":"Mansour","year":"2014","journal-title":"Case Rep Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib98","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/00003226-199803000-00004","article-title":"Role of presensitization and donor-recipient crossmatching in corneal graft outcome","volume":"17","author":"Des Marchais","year":"1998","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib99","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/01.RES.76.3.412","article-title":"Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells","volume":"76","author":"Marx","year":"1995","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.survophthal.2016.12.010_bib100","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00417-003-0724-7","article-title":"Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study","volume":"241","author":"Mayer","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib101","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00003226-198706040-00009","article-title":"Corneal allograft rejection in a pregnant woman","volume":"6","author":"McDonnell","year":"1987","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib102","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib103","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00007890-198803000-00030","article-title":"Successful engraftment of high-risk corneal allografts with short-term immunosuppression with cyclosporine","volume":"45","author":"Miller","year":"1988","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib104","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4049\/jimmunol.164.1.161","article-title":"Dendritic cells genetically engineered to express Fas ligand induce donor-specific hyporesponsiveness and prolong allograft survival","volume":"164","author":"Min","year":"2000","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1076\/ceyr.19.1.53.5338","article-title":"Suppression of experimental corneal angiogenesis by focal X-ray irradiation","volume":"19","author":"Miyamoto","year":"1999","journal-title":"Curr Eye Res"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib106","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0161-6420(89)32757-6","article-title":"Risk of endothelial rejection after bilateral penetrating keratoplasty","volume":"96","author":"Musch","year":"1989","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib107","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1128\/AAC.42.2.216","article-title":"The novel immunosuppressive agent mycophenolate mofetil markedly potentiates the antiherpesvirus activities of acyclovir, ganciclovir, and penciclovir in\u00a0vitro and in\u00a0vivo","volume":"42","author":"Neyts","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib108","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ACI.0b013e32833dfa11","article-title":"High-risk corneal allografts and why they lose their immune privilege","volume":"10","author":"Niederkorn","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib109","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/S0161-6420(86)33581-4","article-title":"Corneal argon laser photocoagulation for neovascularization in penetrating keratoplasty","volume":"93","author":"Nirankari","year":"1986","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib110","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.survophthal.2007.04.008","article-title":"Corneal graft rejection","volume":"52","author":"Panda","year":"2007","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.12.010_bib111","first-page":"67","article-title":"Update on the use of systemic biologic agents in the treatment of noninfectious uveitis","volume":"8","author":"Pasadhika","year":"2014","journal-title":"Biologics"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib112","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00003226-199705000-00005","article-title":"Topical cyclosporin A in the management of postkeratoplasty glaucoma","volume":"16","author":"Perry","year":"1997","journal-title":"Cornea"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib113","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0002-9394(72)90389-3","article-title":"Electron microscopic studies of graft endothelium in corneal graft rejection","volume":"73","author":"Polack","year":"1972","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"10.1016\/j.survophthal.2016.12.010_bib114","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjo.85.12.1464","article-title":"Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study","volume":"85","author":"Poon","year":"2001","journal-title":"Br J Ophthalmol"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2016.12.010_bib115","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1097\/ICO.0000000000000505","article-title":"Evolution of endothelial keratoplasty: Where are we headed?","volume":"34","author":"Price","year":"2015","journal-title":"Cornea"},{"issue":"12","key":"10.1016\/j.survophthal.2016.12.010_bib116","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.ophtha.2009.07.010","article-title":"Descemet's membrane endothelial keratoplasty: Prospective multicenter study of visual and refractive outcomes and endothelial survival","volume":"116","author":"Price","year":"2009","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib117","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.ophtha.2006.05.022","article-title":"Efficacy of topical cyclosporine 0.05% for prevention of cornea transplant rejection episodes","volume":"113","author":"Price","year":"2006","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib118","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0161-6420(95)30842-1","article-title":"Cytologic evidence of corneal diseases with limbal stem cell deficiency","volume":"102","author":"Puangsricharern","year":"1995","journal-title":"Ophthalmology"},{"issue":"Suppl 9","key":"10.1016\/j.survophthal.2016.12.010_bib119","first-page":"1","article-title":"Corneal allograft rejection: immunopathogenesis to therapeutics","volume":"2013","author":"Qazi","year":"2013","journal-title":"J\u00a0Clin Cell Immunol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib120","first-page":"987","article-title":"Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants","volume":"42","author":"Qian","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib121","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.ico.0000178731.42187.46","article-title":"Prevention and treatment of corneal graft rejection: current practice patterns (2004)","volume":"25","author":"Randleman","year":"2006","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.survophthal.2016.12.010_bib122","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0002-9394(14)72437-7","article-title":"Indications for and outcomes of repeat penetrating keratoplasty","volume":"109","author":"Rapuano","year":"1990","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.survophthal.2016.12.010_bib123","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1432-2277.2005.00126.x","article-title":"Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study","volume":"18","author":"Reinhard","year":"2005","journal-title":"Transpl Int"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib124","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004170100285","article-title":"Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years\u2019 results of a randomized prospective clinical trial","volume":"239","author":"Reinhard","year":"2001","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"Suppl","key":"10.1016\/j.survophthal.2016.12.010_bib125","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1007\/BF02343059","article-title":"Systemic ciclosporin A in high-risk keratoplasties","volume":"234","author":"Reinhard","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib126","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/bjo.83.11.1268","article-title":"Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial","volume":"83","author":"Reis","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.survophthal.2016.12.010_bib127","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/ajt.13926","article-title":"The influence of donor and recipient gender incompatibility on corneal transplant rejection and failure","volume":"17","author":"Romano","year":"2017","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.survophthal.2016.12.010_bib128","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bjo.86.9.988","article-title":"Systemic cyclosporin A in high failure risk, repeated corneal transplantation","volume":"86","author":"Rumelt","year":"2002","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib129","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.trre.2013.04.003","article-title":"The impact of calcineurin inhibitors on graft survival","volume":"27","author":"Rush","year":"2013","journal-title":"Transplant Rev"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJM198607033150105","article-title":"Reduced graft rejection with good HLA-A and B matching in high-risk corneal transplantation","volume":"315","author":"Sanfilippo","year":"1986","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.survophthal.2016.12.010_bib131","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.139.6.1797","article-title":"Novel immunosuppressive agent, FK506. In\u00a0vitro effects on the\u00a0cloned T cell activation","volume":"139","author":"Sawada","year":"1987","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib132","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/PL00007114","article-title":"[Immune suppression by combination therapy with basiliximab and cyclosporin in high risk keratoplasty. A pilot study]","volume":"99","author":"Schmitz","year":"2002","journal-title":"Ophthalmologe"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib133","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1055\/s-2008-1045663","article-title":"[Keratoplasty in childhood. Report of 71 keratoplasties]","volume":"203","author":"Sch\u00f6nherr","year":"1993","journal-title":"Klin Monbl Augenheilkd"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.2610140102","article-title":"Rapamycin: a novel immunosuppressive macrolide","volume":"14","author":"Sehgal","year":"1994","journal-title":"Med Res Rev"},{"key":"10.1016\/j.survophthal.2016.12.010_bib135","series-title":"Corneal Surgery, Theory, Technique and Tissues","first-page":"254","article-title":"Rejection","author":"Shapiro","year":"1997"},{"issue":"24","key":"10.1016\/j.survophthal.2016.12.010_bib136","doi-asserted-by":"crossref","first-page":"11205","DOI":"10.1073\/pnas.92.24.11205","article-title":"Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells","volume":"92","author":"Shaw","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajo.2011.01.019","article-title":"Prospective, randomized study of the efficacy of systemic cyclosporine in high-risk corneal transplantation","volume":"152","author":"Shimazaki","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib138","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.ophtha.2003.12.060","article-title":"Influence of donor storage time on corneal allograft survival","volume":"111","author":"Simon","year":"2004","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib139","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0161-6420(01)00759-X","article-title":"Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts","volume":"108","author":"Sloper","year":"2001","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.survophthal.2016.12.010_bib140","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/bjophthalmol-2011-301349","article-title":"Penetrating keratoplasty versus deep anterior lamellar keratoplasty: comparison of optical and visual quality outcomes","volume":"96","author":"S\u00f6\u011f\u00fctl\u00fc Sari","year":"2012","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib141","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":"Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.survophthal.2016.12.010_bib142","first-page":"432","article-title":"Six years' experience with systemic cyclosporin A prophylaxis in high-risk perforating keratoplasty patients. A retrospective study","volume":"1","author":"Sundmacher","year":"1992","journal-title":"Ger J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib143","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/08923970600809447","article-title":"Comparison of FK 506, mycophenolate mofetil, and aminoguanidine effects on delay of corneal allograft rejection in an experimental model of low-risk and high-risk keratoplasty","volume":"28","author":"Svoz\u00edlkov\u00e1","year":"2006","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib144","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/TP.0000000000001044","article-title":"In\u00a0vivo expansion of regulatory T cells by low-dose interleukin-2 treatment increases allograft survival in corneal transplantation","volume":"100","author":"Tahvildari","year":"2016","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1006\/bbrc.1994.1947","article-title":"Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin","volume":"202","author":"Tamura","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.survophthal.2016.12.010_bib146","first-page":"2354","article-title":"Blocking neuropilin-2 enhances corneal allograft survival by selectively inhibiting lymphangiogenesis on vascularized beds","volume":"16","author":"Tang","year":"2010","journal-title":"Mol Vis"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib147","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/S0041-1345(03)00234-3","article-title":"Sirolimus in liver transplantation","volume":"35","author":"Trotter","year":"2003","journal-title":"Transplant Proc"},{"issue":"10","key":"10.1016\/j.survophthal.2016.12.010_bib148","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/bjo.2008.143024","article-title":"Evaluation of topical ciclosporin 0.05% for prevention of rejection in high-risk corneal grafts","volume":"92","author":"Unal","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib149","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/09273948.2010.498657","article-title":"Clinical review: topical ophthalmic use of cyclosporin A","volume":"18","author":"Utine","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib150","first-page":"1210","article-title":"Influence of donor and histocompatibility factors on corneal graft outcome","volume":"58","author":"Vail","year":"1994","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.survophthal.2016.12.010_bib151","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00417-009-1170-y","article-title":"Avastin use in high risk corneal transplantation","volume":"247","author":"Vassileva","year":"2009","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib152","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/ICO.0000000000000391","article-title":"Long-term resolution of immunological graft rejection after a dexamethasone intravitreal implant","volume":"34","author":"Vinciguerra","year":"2015","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.survophthal.2016.12.010_bib153","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00007890-200008270-00018","article-title":"Beneficial effect of HLA-DR matching on the survival of corneal allografts","volume":"70","author":"V\u00f6lker-Dieben","year":"2000","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib154","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1755-3768.1982.tb08374.x","article-title":"The effect of prospective HLA-A and -B matching on corneal graft survival","volume":"60","author":"V\u00f6lker-Dieben","year":"1982","journal-title":"Acta Ophthalmol"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib155","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.ophtha.2013.03.044","article-title":"Topical cyclosporine in the treatment of allergic conjunctivitis: A meta-analysis","volume":"120","author":"Wan","year":"2013","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.survophthal.2016.12.010_bib156","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/01.tp.0000285489.91595.13","article-title":"The immunobiology of corneal transplantation","volume":"84","author":"Williams","year":"2007","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.survophthal.2016.12.010_bib157","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0161-6420(92)31960-8","article-title":"Factors predictive of corneal graft survival. Report from the Australian Corneal Graft Registry","volume":"99","author":"Williams","year":"1992","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib158","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/ICO.0000000000000258","article-title":"Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine","volume":"33","author":"Yamazoe","year":"2014","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.survophthal.2016.12.010_bib159","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/00007890-199812150-00016","article-title":"Effect of a topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat","volume":"66","author":"Yatoh","year":"1998","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.survophthal.2016.12.010_bib160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5500\/wjt.v6.i1.10","article-title":"High-risk corneal allografts: A therapeutic challenge","volume":"6","author":"Yu","year":"2016","journal-title":"World J Transplant"},{"issue":"7","key":"10.1016\/j.survophthal.2016.12.010_bib161","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1167\/iovs.08-1899","article-title":"Depletion of passenger leukocytes from corneal grafts: an effective means of promoting transplant survival?","volume":"50","author":"Zhang","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2016.12.010_bib162","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-9394(14)73872-3","article-title":"Local therapy of corneal allograft rejection with cyclosporine","volume":"119","author":"Zhao","year":"1995","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2016.12.010_bib163","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1097\/00007890-200003150-00061","article-title":"ICAM-1 deficiency suppresses host allosensitization and rejection of MHC-disparate corneal transplants","volume":"69","author":"Zhu","year":"2000","journal-title":"Transplantation"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625716301485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625716301485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T11:45:37Z","timestamp":1758541537000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625716301485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":163,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0039625716301485"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2016.12.010","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of high-risk corneal transplantation","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2016.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}